Health insurance in America costs more than in any other wealthy nation, and it’s not close. The U.S. spends 17.2% of its GDP on healthcare, compared to an average of 11.2% among peer countries. For a typical family with employer-sponsored coverage, that translates to an average annual premium of $26,993 in 2025. Individual coverage averages $9,325. These numbers reflect a system where multiple forces push costs upward simultaneously, with no single villain to blame.
Providers Earn More Than Anywhere Else
American doctors, hospitals, and other providers charge significantly higher prices than their counterparts in other countries, and those prices flow directly into your premiums. Physicians at the 98th percentile of earnings in the U.S. make over $500,000 a year. Doctors at the same level in Canada, Sweden, or the Netherlands earn roughly $200,000. At the very top, the gap is even wider: the highest-earning American physicians bring in around $1 million individually, compared to less than $400,000 for top earners in Sweden or the Netherlands.
Stanford researchers estimated that bringing average U.S. physician incomes down to Swedish levels would mean a 75% pay cut, roughly $342,800 per doctor. That gives you a sense of the scale. Higher provider pay isn’t just about physician salaries, either. Hospitals charge more for procedures, imaging, and lab work than facilities in comparable countries. A knee replacement, an MRI, or even a routine blood panel simply costs more here, and insurers pass those costs along to you.
Brand-Name Drug Prices Dwarf International Norms
Americans pay at least 3.22 times as much for brand-name prescription drugs as consumers in other high-income countries, even after accounting for the rebates that manufacturers negotiate with insurers. That figure comes from the U.S. Department of Health and Human Services, and it reflects a fundamental structural difference: most other countries have government bodies that negotiate drug prices or set maximum reimbursement rates. The U.S. has historically allowed manufacturers to set their own prices for most of the market.
Prescription drugs are a growing share of total healthcare spending, and expensive specialty medications for conditions like cancer, autoimmune diseases, and rare genetic disorders drive much of the increase. When insurers pay more for drugs, those costs get baked into premiums for everyone in the risk pool, whether you take expensive medications or not.
Hospital Consolidation Reduces Competition
When hospitals merge, they gain leverage to negotiate higher reimbursement rates from insurers. Research published in Health Affairs found that areas with the highest hospital market concentration had annual premiums about $424 higher, roughly 5%, than areas with the most competition. That may sound modest, but it compounds across millions of policyholders and stacks on top of every other cost driver.
The trend has accelerated over the past two decades. In many regions, a single health system now controls most of the hospital beds and specialist practices. When an insurer can’t build a network without including that system, it has little bargaining power. The system names its price, the insurer agrees, and your premium absorbs the difference.
The Fee-for-Service Payment Model
Most American healthcare still operates on a fee-for-service basis, meaning providers get paid for each test, visit, and procedure they perform. The more they do, the more they earn. This creates a built-in incentive to order additional imaging, schedule follow-up visits, and choose more intensive treatments, even when a simpler approach would produce the same outcome.
Consider a patient with a manageable chronic condition. Under fee-for-service, repeated visits for something that could be addressed and controlled in fewer appointments generate far higher costs. The model doesn’t reward keeping patients healthy or resolving problems efficiently. It rewards volume. Some insurers and health systems have shifted toward value-based arrangements that tie payment to patient outcomes instead, but fee-for-service remains the dominant structure, and its incentives continue to inflate overall spending.
Chronic Disease Drives 90% of Spending
The CDC reports that 90% of the nation’s $4.9 trillion in annual healthcare expenditures go toward people with chronic and mental health conditions. Diabetes, heart disease, obesity-related complications, and mental health disorders are extraordinarily common in the U.S. population, and managing them is expensive over a lifetime. Insulin, blood pressure medications, dialysis, cardiac procedures, and ongoing specialist visits add up fast.
This isn’t just a medical problem. It’s an insurance math problem. When such a large share of the insured population requires ongoing, expensive care, premiums for everyone in the pool rise to cover those costs. The prevalence of chronic conditions in America is higher than in most peer nations, partly due to diet, lifestyle, and gaps in preventive care that allow conditions to progress before they’re caught.
Administrative Complexity Adds Layers of Cost
The American system involves thousands of private insurers, each with its own billing codes, coverage rules, prior authorization processes, and claims procedures. Hospitals and physician practices employ large administrative staffs just to navigate this patchwork. The billing department at a U.S. hospital is often one of its largest teams, a cost that barely exists in single-payer systems where one entity handles reimbursement.
From the insurer side, there’s marketing, broker commissions, underwriting, and compliance with state-by-state regulations. The Affordable Care Act requires insurers to spend at least 80% of premium dollars on actual medical care (85% for large group plans), which caps but doesn’t eliminate the administrative and profit overhead. That remaining 15 to 20% of premiums, across a multi-trillion-dollar industry, represents an enormous sum.
Your Costs Are Growing Faster Than Your Income
Even if premiums were stable, the shift in how costs are distributed would still make insurance feel more expensive. Average deductibles have climbed steadily: for middle-income households, the deductible alone consumed 4.7% of household income in 2020, up from 3.3% in 2010. When you combine premium contributions and deductibles, employer-sponsored health plans ate up 11.6% of median household income in 2020, compared to 9.1% a decade earlier.
Wages simply haven’t kept pace. The result is that even people with “good” insurance through their jobs are paying a larger and larger share of their earnings for coverage that often comes with higher out-of-pocket costs than it did ten years ago. A $26,993 family premium in 2025 represents a significant financial burden even when an employer covers a portion of it, because the employee’s share has grown alongside the total.
Why These Problems Persist
Each cost driver reinforces the others. High provider prices make chronic disease management more expensive. Fee-for-service incentives generate more utilization. Hospital consolidation removes the competitive pressure that might otherwise push prices down. Administrative complexity adds friction and cost at every transaction. And the sheer size of the industry, touching nearly one-fifth of the entire economy, means that every stakeholder with a financial interest has strong motivation to resist changes that would reduce their revenue.
Other wealthy nations have controlled costs through some combination of government price-setting, single-payer administration, global hospital budgets, or regulated competition among nonprofit insurers. The U.S. relies more heavily on market forces, but the healthcare market doesn’t behave like a normal market. You can’t comparison-shop during an emergency, you rarely know the price before receiving care, and your employer typically chooses your plan options for you. That combination of market-based pricing without actual market dynamics is a core reason American health insurance remains uniquely expensive.